A narrative review of the literature on the treatment of multiple sclerosis
PDF (Português (Brasil))

Keywords

Parkinson's Disease
Neurodegeneration
Emerging Therapies
Monitoring Technologies
Clinical Trials

How to Cite

Pereira Levada, L., De Souza Barbosa, J. L., Neto de Souza Ferreira, E., Martins Marinho, A., Fonseca Ferraz, L., Castro Milazzo, B., Naves Dias Azevedo, J. A., Ferraz Medeiros, R., Catarina Belizio da Silva, K., Cristina Teixeira, C., Freitas Santos, A., Caroline Marinho Dantas, L., de Medeiros Jardim Pacheco, G., Railla Barbalho Alves, A., & Aguiar Alencar de Oliveira, V. (2024). A narrative review of the literature on the treatment of multiple sclerosis. Brazilian Journal of Implantology and Health Sciences, 6(3), 2397–2408. https://doi.org/10.36557/2674-8169.2024v6n3p2397-2408

Abstract

Parkinson's disease (PD) is a complex neurodegenerative condition characterized by debilitating motor and non-motor symptoms resulting from the progressive loss of dopaminergic neurons. This text reviews a variety of emerging therapeutic strategies for PD, ranging from stem cell-based therapies to novel pharmacological approaches, such as the use of antidiabetic agents and modulation of the kynurenine enzymatic system. While these approaches offer hope for halting disease progression, they face ethical, technical, and clinical challenges that need to be addressed to ensure their clinical success. Additionally, technologies like wearables and motion analysis offer innovative ways to monitor and optimize PD treatment, though they also present standardization and correlation challenges with other disease markers. Ultimately, a multidisciplinary and careful approach, coupled with robust clinical trials, is essential to realize the full potential of these interventions and improve the quality of life for patients with PD and other neurodegenerative conditions. 

https://doi.org/10.36557/2674-8169.2024v6n3p2397-2408
PDF (Português (Brasil))

References

AMIRIAN, R. et al. Targeted protein degradation for the treatment of Parkinson’s disease: Advances and future perspective. Biomedicine & Pharmacotherapy, v. 166, p. 115408, 1 out. 2023. ‌

BICKNELL, B.; LIEBERT, A.; HERKES, G. Parkinson’s Disease and Photobiomodulation: Potential for Treatment. Journal of Personalized Medicine, v. 14, n. 1, p. 112–112, 19 jan. 2024. ‌

BRASIL. Lei Nº 12.853. Brasília: 14 de agosto de 2013.

BURTSCHER, J. et al. Exercise and gait/movement analyses in treatment and diagnosis of Parkinson’s Disease. Ageing Research Reviews, v. 93, p. 102147, 1 jan. 2024. ‌

CATTANEO, C.; JOST, W. H. Pain in Parkinson’s Disease: Pathophysiology, Classification and Treatment. Journal of Integrative Neuroscience, v. 22, n. 5, p. 132, 8 set. 2023. ‌

CHEN, P.; GENG, X. Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry, v. 38, n. 1, 29 jun. 2023. ‌

EKER, F. et al. Lactoferrin: neuroprotection against Parkinson’s disease and secondary molecule for potential treatment. Frontiers in Aging Neuroscience, v. 15, 5 set. 2023. ‌

EMMI PAKARINEN; LINDHOLM, P. CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease. Frontiers in Psychiatry, v. 14, 24 jul. 2023. ‌

FABBRI, M.; BARBOSA, R.; RASCOL, O. Off-time Treatment Options for Parkinson’s Disease. Neurology and Therapy, 12 jan. 2023. ‌

ISAACSON, S. et al. Dopamine Agonists in Parkinson’s Disease: Impact of D1-like or D2-like Dopamine Receptor Subtype Selectivity and Avenues for Future Treatment. Clinical parkinsonism & related disorders, v. 9, p. 100212–100212, 1 jul. 2023.

NOWELL, J. et al. Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease. Ageing Research Reviews, v. 89, p. 101979, 1 ago. 2023. ‌

PACCOSI, E.; LUCA PROIETTI-DE-SANTIS. Parkinson’s Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy. v. 24, n. 11, p. 9547–9547, 31 maio 2023. ‌

REICHMANN, H.; KLINGELHOEFER, L.; BENDIG, J. The use of wearables for the diagnosis and treatment of Parkinson’s disease. Journal of Neural Transmission, 7 jan. 2023. ‌

SALIM, S. et al. Gut microbiome and Parkinson’s disease: Perspective on pathogenesis and treatment. Journal of Advanced Research, 1 nov. 2022. ‌

WANG, Y. et al. Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson’s disease. Neurobiology of Disease, v. 184, p. 106224, 1 ago. 2023.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Leonardo Pereira Levada, Júlia Letícia De Souza Barbosa, Ezo Neto de Souza Ferreira, Amanda Martins Marinho, Luísa Fonseca Ferraz, Brendha Castro Milazzo, João Antônio Naves Dias Azevedo, Rebeca Ferraz Medeiros, Késsia Catarina Belizio da Silva, Carla Cristina Teixeira, Amanda Freitas Santos, Lorena Caroline Marinho Dantas, Gabriel de Medeiros Jardim Pacheco, Anna Railla Barbalho Alves, Victor Aguiar Alencar de Oliveira